Concurrent Investment Advisors’s Angel Oak Income ETF CARY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$454K Sell
22,575
-20,694
-48% -$427K ﹤0.01% 1626
2026
Q2
$899K Buy
43,269
+2,081
+5% +$43.3K 0.01% 1061
2026
Q1
$856K Buy
41,188
+782
+2% +$16.4K 0.01% 944
2025
Q4
$841K Buy
40,406
+19,811
+96% +$415K 0.01% 912
2025
Q3
$431K Buy
20,595
+5,407
+36% +$113K 0.01% 977
2025
Q2
$316K Sell
15,188
-323
-2% -$6.68K 0.01% 1045
2025
Q1
$322K Buy
15,511
+256
+2% +$5.3K 0.01% 894
2024
Q4
$314K Sell
15,255
-61
-0.4% -$1.27K 0.01% 811
2024
Q3
$325K Buy
15,316
+262
+2% +$5.5K 0.01% 754
2024
Q2
$310K Buy
15,054
+51
+0.3% +$1.04K 0.01% 726
2024
Q1
$308K Sell
15,003
-4,758
-24% -$97.5K 0.01% 666
2023
Q4
$404K Buy
+19,761
New +$399K 0.02% 547

Other funds holding CARY

Concurrent Investment Advisors's CARY Position: Q3 2026 in Review

Concurrent Investment Advisors reduced its Angel Oak Income ETF (CARY) stake by 48% in Q3 2026, selling an estimated $427K and leaving 22,575 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Concurrent Investment Advisors first reported a position in CARY in Q4 2023 and has held it in 12 quarters since. The position peaked at $899K in Q2 2026. 103 funds tracked by Wall St. Rank hold CARY as of Q3 2026.

  • Concurrent Investment Advisors held 22,575 shares of Angel Oak Income ETF worth $454K as of Q3 2026.
  • Concurrent Investment Advisors sold 20,694 Angel Oak Income ETF shares in Q3 2026, an estimated $427K.
  • Angel Oak Income ETF made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q3 2026, its #1626 holding.
  • Concurrent Investment Advisors first reported a position in Angel Oak Income ETF in Q4 2023 and has held it in 12 quarters since.
  • Concurrent Investment Advisors's Angel Oak Income ETF position peaked at $899K in Q2 2026.
  • 103 funds tracked by Wall St. Rank held Angel Oak Income ETF as of Q3 2026.

Based on Concurrent Investment Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.